Patriot Scientific

Patriot Scientific Reports Profitable Quarter; Q3 FY '08 Net Income $6.3 Million or $0.02 Basic and Diluted Earnings Per Share.
in response to ease2002's message
Many issuers of the debt are now refinancing these obligations (because they do not want to pay the higher re-set rates) which will help begin to ease the seizing up of the whole market. A lot of the refinancings I have seen are in the municipal sector, but I would imagine similar work is underway in the student loan sector, although I don't know for sure. This will take time to play out in its entirety, but to list the ARS as a short-term investment (essentially meaning it can be turned into cash in less than 12 months) is an indication that management and our audit firm (even though a Q itself is not audited) have deliberated on the matter and determined the treatment to be proper (for now). I have read a few other Q's issued by other companies that have the same situation, and I did not see any of them recording impairment charges (yet), but you can be sure they are monitoring it constantly and weighing all options based on the quality of the instrument and their short term cash needs vs. the options avaliable for quick liquidation.
Please login to post a reply
BUSHleague
City
Rank
Treasurer
Activity Points
7387
Rating
Your Rating
Date Joined
02/22/2005
Social Links
Private Message
Patriot Scientific
Symbol
PTSC
Exchange
OTCBB
Shares
401,392,948
Industry
Technology & Medical
Website
Create a Post